Pharmaceutical Pfizer confirmed that it already has approval from the United States Food and Drug Administration (FDA) to include children between 12 and 15 years of age in its clinical trial of an experimental vaccine against coronavirus. .
According to Pfizer, many parents have already expressed interest in having their children included in the tests.